BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Lupus Nephritis
Interventions
BIOLOGICAL

BIIB023

BIOLOGICAL

Placebo

DRUG

mycophenolate mofetil

titrated to a target daily dose of 2 g (1 g twice daily)

DRUG

oral corticosteroids

oral corticosteroids (prednisone or equivalent) at a target prednisone dose of 10 mg/day

Trial Locations (58)

1015

Research Site, Manila

1097

Research Site, Budapest

1102

Research Site, Quezon City

3000

Research Site, Leuven

3050

Research Site, Melbourne

4000

Research Site, San Miguel de Tucumán

Research Site, Liège

4032

Research Site, Debrecen

5000

Research Site, Córdoba

10330

Research Site, Patumwan

10700

Research Site, Bangkoknoi

10990

Research Site, Pulau Pinang

11020

Research Site, Lake Success

14000

Research Site, Mexico City

25000

Research Site, Saltillo

30990

Research Site, Ipoh

32806

Research Site, Orlando

33604

Research Site, Pessac

37000

Research Site, León

38119

Research Site, Memphis

41200

Research Site, Selangor Darul Ehsan

43000

Research Site, Kuala Selangor

43210

Research Site, Columbus

46520

Research Site, Sagunto

55131

Research Site, Mainz

56126

Research Site, Pisa

59037

Research Site, Lille

59100

Research Site, Kuala Lumpur

75651

Research Site, Paris

78240

Research Site, San Luis Potosí City

79905

Research Site, El Paso

90509

Research Site, Torrance

93586

Research Site, Kuching

94010

Research Site, Paris

123182

Research Site, Moscow

197022

Research Site, Saint Petersburg

02118

Research Site, Boston

Unknown

Research Site, Rochester

Research Site, Ciudad Autonoma Buenos Aires

Research Site, San Miguel de Tucumán

Research Site, Barranquilla

Research Site, Bogotá

Research Site, Medellín

Research Site, Hong Kong

Research Site, Shatin

Research Site, Lima

27599-7025

Research Site, Chapel Hill

C1015ABO

Research Site, Capital Federal

B1902COS

Research Site, La Plata

5402DIL

Research Site, San Juan

78048-902

Research Site, Cuiabá

04027-000

Research Site, São Paulo

06090

Research Site, Cuauhtémoc

92-153

Research Site, Lodz

50-417

Research Site, Wroclaw

3000-075

Research Site, Coimbra

602-715

Research Site, Busan

443-721

Research Site, Gyeonggi-do

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY

NCT01499355 - BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis | Biotech Hunter | Biotech Hunter